Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

McMaster University

$25,000.00

Delivery system for novel back of the eye compounds

EF 2014-15

Résumé
Delivery of drugs to the back of the eye is hindered by the presence of natural barriers that are in place to protect the delicate ocular structures. While injections have been shown to be effective, the frequency with which they must be administered is both inconvenient for the patient and physician and carries with it a significant risk of complications. Inception Sciences, a Vancouver and Montreal based drug discovery company has several lead compounds that have potential to treat the most prevalent disease of the back of the eye, age related macular degeneration. However long term administration is necessary. Therefore the project is aimed at developing an injectable nanoparticle system, based on two polymers that have been previously shown to have promise for delivery of the compounds to the eye but which have significant limitations. The hypothesis is that by combining these two materials, a novel material that overcomes the limitations can be developed and that this new material can provide long term (approximately 6 month) delivery of compounds to the back of the eye.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
477041-2014
Name nom
Sheardown, Heather
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
1
Application title
Delivery system for novel back of the eye compounds
Keyword
NSERC
Application summary
Delivery of drugs to the back of the eye is hindered by the presence of natural barriers that are in place to protect the delicate ocular structures. While injections have been shown to be effective, the frequency with which they must be administered is both inconvenient for the patient and physician and carries with it a significant risk of complications. Inception Sciences, a Vancouver and Montreal based drug discovery company has several lead compounds that have potential to treat the most prevalent disease of the back of the eye, age related macular degeneration. However long term administration is necessary. Therefore the project is aimed at developing an injectable nanoparticle system, based on two polymers that have been previously shown to have promise for delivery of the compounds to the eye but which have significant limitations. The hypothesis is that by combining these two materials, a novel material that overcomes the limitations can be developed and that this new material can provide long term (approximately 6 month) delivery of compounds to the back of the eye.